MergerLinks Header Logo
Cover Image Ryoichi Nagata
Ryoichi NagataSHIN NIPPON BIOMED LAB

Ryoichi Nagata

CEO at SHIN NIPPON BIOMED LAB

Manager

Deal Bio

Total Deals2
Valued Deals2
Total Value£197M
Avg. Deal Size£99M

Sort

Japan
Medical Services
AcquisitionPublicMajorityDomestic
Ina Research

target

Ina Research

Shin Nippon Biomed Lab

bidder

Shin Nippon Biomed Lab

£19m

6 dealmakers

United States
Pharmaceuticals
Cross BorderAcquisitionMajorityPublic
Satsuma Pharmaceuticals

target

Satsuma Pharmaceuticals

Shin Nippon Biomed Lab

bidder

Shin Nippon Biomed Lab

£177m

6 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US